Xiaodong Wang, Director at BeOne Medicines Ltd. (ONC), sold 2,514 shares at $263.50 ($668K) on 2025-06-24, disclosed to the SEC on 2025-06-25.
Scheduled sale ($668k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $263.50 | 300 | $79K | 11.8% |
| 2 | $265.35 | 1,100 | $292K | 43.7% |
| 3 | $266.57 | 507 | $135K | 20.2% |
| 4 | $266.57 | 507 | $135K | 20.2% |
| 5 | $267.81 | 100 | $27K | 4.0% |
| Total | $265.72 avg | 2,514 |
| $668K |
| 100% |
| Filing → |
| ONC | SELL | 2025-06-12 | $21.9M | — | Filing → |
| BGNE | SELL | 2025-05-15 | $18.6M | — | Filing → |
| BGNE | SELL | 2025-04-16 | $20.3M | — | Filing → |